MiR-133b inhibits MPP+-induced apoptosis in Parkinson's disease model by inhibiting the ERK1/2 signaling pathway.
Dong LG, Lu FF, Zu J, Zhang W, Xu CY, Jin GL, Yang XX, Xiao QH, Cui CC, Xu R, Zhou S, Zhu JN, Shen T, Cui GY.
Dong LG, et al. Among authors: zhang w.
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11192-11198. doi: 10.26355/eurrev_202011_23607.
Eur Rev Med Pharmacol Sci. 2020.
PMID: 33215437
Free article.